Dow Jones Newswires: Acelyrin boosts IPO size, maintains expected price range

May 4, 2023

Acelyrin plans to increase its initial public offering to 26.5 million shares of its common stock.

The late-stage clinical biopharma company had previously said it would offer 20.6 million shares.

The IPO price will remain between $16 and $18 a share, Acelyrin said in a filing with the Securities and Exchange Commission on Wednesday.

Acelyrin…

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…